132 related articles for article (PubMed ID: 30090635)
21. Guillain-Barré Syndrome and Posterior Reversible Encephalopathy Syndrome following Spinal Surgery.
Sanpei Y; Hanazono A; Kamada S; Sugawara M
Case Rep Neurol; 2019; 11(3):284-289. PubMed ID: 31607895
[TBL] [Abstract][Full Text] [Related]
22. Guillain-Barré Syndrome After Revision Lumbar Surgery: A Case Report.
Rashid A; Kurra S; Lavelle W
Cureus; 2017 Jun; 9(6):e1393. PubMed ID: 28845372
[TBL] [Abstract][Full Text] [Related]
23. Hyponatremia is a predictor for poor outcome in Guillain-Barré syndrome.
Wang Y; Liu J
Neurol Res; 2015 Apr; 37(4):347-51. PubMed ID: 25366666
[TBL] [Abstract][Full Text] [Related]
24. Patient characteristics and the effects of intravenous immunoglobulin in patients with Guillain-Barre syndrome.
Guzey Aras Y; Tanik O; Dogan Güngen B; Kotan D
Ideggyogy Sz; 2016 Nov; 69(11-12):389-395. PubMed ID: 29733556
[TBL] [Abstract][Full Text] [Related]
25. Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia.
Steinberger BA; Ford SM; Coleman TA
Am J Hematol; 2003 Jun; 73(2):97-100. PubMed ID: 12749010
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
Kanra G; Ozon A; Vajsar J; Castagna L; Secmeer G; Topaloglu H
Eur J Paediatr Neurol; 1997; 1(1):7-12. PubMed ID: 10728186
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of a 12-year-old boy with Guillain-Barré syndrome requiring tracheostomy due to respiratory muscle paralysis: A case report.
Miyamoto M; Imataka G; Ichikawa G; Saito Y; Kashiwagi T; Kaji Y; Wake K; Funakoshi K; Nagashima T; Kokubun N; Yoshihara S
Exp Ther Med; 2020 Feb; 19(2):1091-1094. PubMed ID: 32010274
[TBL] [Abstract][Full Text] [Related]
28. The Efficacy of Intravenous Immunoglobulin in Guillain-Barré Syndrome: The Experience of a Tertiary Medical Center.
Shalem D; Shemer A; Shovman O; Shoenfeld Y; Kivity S
Isr Med Assoc J; 2018 Dec; 20(12):754-760. PubMed ID: 30550005
[TBL] [Abstract][Full Text] [Related]
29. High-dose immunoglobulin therapy for Guillain-Barré syndrome in Japanese children.
Yata J; Nihei K; Ohya T; Hirano Y; Momoi M; Maekawa K; Sakakihara Y;
Pediatr Int; 2003 Oct; 45(5):543-9. PubMed ID: 14521529
[TBL] [Abstract][Full Text] [Related]
30. Guillain-Barre syndrome and SIADH.
Saifudheen K; Jose J; Gafoor VA; Musthafa M
Neurology; 2011 Feb; 76(8):701-4. PubMed ID: 21339497
[TBL] [Abstract][Full Text] [Related]
31. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
[TBL] [Abstract][Full Text] [Related]
32. CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature.
Spagnoli C; Iodice A; Salerno GG; Frattini D; Bertani G; Pisani F; Fusco C
Eur J Paediatr Neurol; 2016 Jan; 20(1):168-75. PubMed ID: 26621312
[TBL] [Abstract][Full Text] [Related]
33. Guillain-Barré Syndrome During Ongoing Zika Virus Transmission - Puerto Rico, January 1-July 31, 2016.
Dirlikov E; Major CG; Mayshack M; Medina N; Matos D; Ryff KR; Torres-Aponte J; Alkis R; Munoz-Jordan J; Colon-Sanchez C; Salinas JL; Pastula DM; Garcia M; Segarra MO; Malave G; Thomas DL; Rodríguez-Vega GM; Luciano CA; Sejvar J; Sharp TM; Rivera-Garcia B
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(34):910-4. PubMed ID: 27584942
[TBL] [Abstract][Full Text] [Related]
34. Intravenous immunoglobulin and Guillain-Barré syndrome.
Harel M; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of hemolytic anemia in patients with GBS treated with high-dose IVIg.
Nguyen TP; Biliciler S; Wahed A; Sheikh K
Neurol Neuroimmunol Neuroinflamm; 2014 Dec; 1(4):e50. PubMed ID: 25520957
[TBL] [Abstract][Full Text] [Related]
36. Syndrome of inappropriate antidiuretic hormone secretion related to Guillain-Barré syndrome after laparoscopic cholecystectomy.
Çakırgöz MY; Duran E; Topuz C; Kara D; Turgut N; Türkmen ÜA; Turanç B; Dolap MÖ; Hancı V
Braz J Anesthesiol; 2014; 64(3):195-8. PubMed ID: 24907880
[TBL] [Abstract][Full Text] [Related]
37. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
Puma A; Benoit J; Sacconi S; Uncini A
BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
[TBL] [Abstract][Full Text] [Related]
38. Hyponatremia in the postoperative craniofacial pediatric patient population: a connection to cerebral salt wasting syndrome and management of the disorder.
Levine JP; Stelnicki E; Weiner HL; Bradley JP; McCarthy JG
Plast Reconstr Surg; 2001 Nov; 108(6):1501-8. PubMed ID: 11711918
[TBL] [Abstract][Full Text] [Related]
39. The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action.
Shahrizaila N; Yuki N
Expert Opin Pharmacother; 2011 Jul; 12(10):1551-60. PubMed ID: 21473704
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.
Davidson AI; Halstead SK; Goodfellow JA; Chavada G; Mallik A; Overell J; Lunn MP; McConnachie A; van Doorn P; Willison HJ
J Peripher Nerv Syst; 2017 Mar; 22(1):4-12. PubMed ID: 27801990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
